Phillip A. Horwitz, MD

Original Contribution

Single Versus Double Stenting for Unprotected Left Main Coronary Artery Bifurcation Lesions: A Systematic Review and Meta-Analysis

06/02/2014

Saket Girotra , MBBS;

Peter Cram , MD;

Phillip A. Horwitz , MD;

Wassef Karrowni , MD;

Nader Makki , MD;

Amandeep S. Dhaliwal , MDCM;

Ankur Vyas , MBBS;

Amy Blevins ;

Saadeddine Dughman , MD;

PCI for unprotected left main coronary artery bifurcation lesions continues to be technically demanding and is an independent predictor of poor outcomes. We conducted a meta-analysis that assesses outcomes for a single-stent strategy versus a...

PCI for unprotected left main...

06/02/2014

Journal of Invasive Cardiology

Case Report

Cardiac Mass Presenting as ST-Elevation Myocardial Infarction: Case Report and Review of the Literature

11/04/2008

Phillip A. Horwitz , MD;

Guarav Aggarwala , MD;

Nikhil Iyengar , MD;

ABSTRACT: We discuss the case of a 71-year-old female patient who presented with findings suggestive of an acute myocardial infarction. Subsequent evaluation revealed an extrinsic cardiac mass encasing the left circumflex and right coronary...

ABSTRACT: We discuss the case of...

11/04/2008

Journal of Invasive Cardiology

Rapid Communication

Desensitization for the Management of Clopidogrel Hypersensitivity: Initial Clinical Experience

08/01/2008

Nicholas E. Walker , MD;

Mary Beth Fasano , MD;

Phillip A. Horwitz , MD;

Clopidogrel bisulfate is a thienopyridine oral antiplatelet agent that acts via irreversible inhibition of adenosine diphosphate-mediated platelet activation and aggregation.1 It is widely used in the treatment and secondary prevention of a...

Clopidogrel bisulfate is a...

08/01/2008

Journal of Invasive Cardiology